CTLA-4 overexpression in CD19+/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients [8]

Leukemia

Volumn 19, Issue 2, 2005, Pages 301-304

  Kosmaczewska, A ^a   Ciszak, L ^a   Suwalska, K ^a   Wolowiec, D ^b   Frydecka, I ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENOMIC DNA;

ALLELE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; B LYMPHOCYTE; CANCER STAGING; CELL ACTIVATION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DNA POLYMORPHISM; ENZYME SYNTHESIS; FLOW CYTOMETRY; GENOTYPE; HETEROZYGOTE DETECTION; HUMAN; LETTER; LEUKEMIA CELL; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; UPREGULATION;

EID: 13544259946     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403588     Document Type: Letter

References (7)

1. Brunner MC, Chambers CA, Chan FK, Hanke J, Winoto A, Allison JP. CTLA-4-mediated inhibition of early events of T cell proliferation. J Immunol 1999; 162: 5813-5820.
2. Greenwald RJ, Oosterwegel MA, van der Woude D, Kubal A, Mandelbrot DA, Boussiotis VA et al. CTLA-4 regulates cell cycle progression during a primary immune response. Eur J Immunol 2002; 32: 366-373.
3. Wolowiec D, Ciszak L, Kosmaczewska A, Bocko D, Teodorowska R, Frydecka I et al. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. Haematologica 2001; 86: 1249-1257.
4. Ligers A, Teleshova N, Marterman T, Huang WX, Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001; 2: 145-152.
5. Rossmann ED, Lewin N, Jeddi-Tehrani M, Osterborg A, Mellstedt H. Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL). Eur J Haematol 2002; 68: 299-306.
6. Pistillo MP, Tazzari PL, Palmisano GL, Pierri I, Bolognesi A, Ferlito F et al. CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. Blood 2003; 101: 202-209.
7. Wang XB, Kakoulidou M, Giscombe R, Qiu Q, Huang DR, Pirskanen R et al. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol 2002; 130: 224-232.